Crawford, Thomas O.
Johns Hopkins University · Johns Hopkins Medicine · Johns Hopkins Hospital
3 papers on CoChatORCID 0000-0003-0916-2797
Most cited papers
- Verified
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
Day, J. W., Finkel, R. S., Chiriboga, C. A., Connolly, A. M., Crawford, T. O., Darras, B. T., Iannaccone, S. T., Kuntz, N. L., Peña, L. D. M., Shieh, P. B., et al. (2021) · The Lancet Neurology
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 494
- Verified
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects
Sheikh, K. A., Sun, J., Liu, Y., Kawai, H., Crawford, T. O., Proia, R. L., Griffin, J. W., & Schnaar, R. L. (1999) · Proceedings of the National Academy of Sciences
Lysosomal Storage Disorders ResearchGlycosylation and Glycoproteins Research
Cited by 396
- Verified
Ataxia telangiectasia
Crawford, T. O. (1998) · Seminars in Pediatric Neurology
DNA Repair MechanismsGenetic Neurodegenerative Diseases
Cited by 140
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free